Hedy Kindler to Protein Kinase C-alpha
This is a "connection" page, showing publications Hedy Kindler has written about Protein Kinase C-alpha.
Connection Strength
0.013
-
Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancer. Clin Cancer Res. 2002 Apr; 8(4):1042-8.
Score: 0.013